FDA Investigator Shari L Kahn

Shari L Kahn has inspections in 2 countries as of 23 Oct 2023. Shari L Kahn has collaborated with a combined 1623 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America
Alice S Tsao, Althea A Williams, Amy W Mai, Amy W Yan Mai, Andrew J Garufi, Andrew M Abramowitz, Ann M Stewart, Avital A Shimanovich, Aziz A Mamur, Bijoy Panicker, Charanjeet Jassal, Charisse K Green, Daniel L Zheng, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Dipesh K Shah, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edouard Viard, Erik W Koester, Evan Tong, Felix Maldonado, Frank Verni, Gary J Lehr, Gary T Greco, Gray, Helen B Ricalde, Iram R Hassan, PhD, Irina Gaberman, Jaison J Eapen, James A Liubicich, Jay T Wong, Jazmine N Brown, Jazmine N Still, John A Podsadowski, Jose O Hernandez, Joseph Maselli, Joy P Matthias, Juanita P Versace, Judy Friedman, Kevin A Gonzalez, Kimberly Y Smithson, Kwong P Lee, Lawrence W Farina, Manhar R Patel, Marie Bbuen Bigornia, Matthew A Spataro, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Michael R Dominick, Mindy M Chou, Nariman Patenaude, Nazmul Hassan, Nicholas A Violand, Nicole Vaught, Parul M Patel, Paul Mouris, Perry T Nichols, Peter Abel, Peter R Caparelli, Ramon A Hernandez, Rober C Horan, PhD, Robert C Steyert, Robert E Moncayo, Rochelle K Kimmel, Ronald Ifraimov, Samina S Khan, Samuel T Walker, Sarah A Meehan, Sarah A Wangseng, Simone E Pitts, Sonia E Ortiz, Sony Mathews, State Agency, Stephanie T Durso, Steven M Weinman, Sunita Vij, Susan M Jackson, Susant Hadman, Suwaskie S Smith, Syeda N Mahazabin, Thomas J Arista, Thomas J Mccrey, Thomas J Mooney, Thomas S Arista, Tracy M Portelli, Uduak M Inokon, Valerie A Potopsingh, Vanessa M Williams, Xiaoping Guan, Yuyan Liang

Shari L Kahn's Documents

Publish Date Document Type Title
August, 2001 FDA 483 Response Bristol-myers Squibb Pharma Company - Form 483R, 2001-09-06
June, 2000 FDA 483 American Regent, Inc. - Form 483, 2000-06-16
March, 2001 EIR Bristol-myers Squibb Pharma Company - EIR, 2001-03-14
December, 2000 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2000-12-21
August, 2001 EIR Bristol-myers Squibb Pharma Company - EIR, 2001-08-24
June, 2000 FDA 483 Response American Regent, Inc. - Form 483R, 2000-06-30
March, 2001 FDA 483 Response Bristol-myers Squibb Pharma Company - Form 483R, 2001-03-29
July, 2001 EIR TIME CAP LABORATORIES, INC - EIR, 2001-07-13
August, 2000 FDA 483 Perrigo New York, Inc. - Form 483, 2000-08-10
March, 2001 FDA 483 Response Endo Pharmaceutical, Inc. - Form 483R, 2001-04-09
August, 2000 EIR Perrigo New York, Inc. - EIR, 2000-08-10
March, 2001 FDA 483 Endo Pharmaceuticals Inc - Form 483, 2001-03-13
December, 2000 EIR PDK Labs, Inc - EIR, 2000-12-12
July, 2001 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2001-07-13
March, 2001 FDA 483 Bristol-myers Squibb Pharma Company - Form 483, 2001-03-14
June, 2000 EIR American Regent, Inc. - EIR, 2000-06-16
January, 2001 EIR Corwood Labs Inc - EIR, 2001-01-04
March, 2001 EIR Endo Pharmaceutical, Inc. - EIR, 2001-03-13
July, 2001 FDA 483 Response TIME CAP LABORATORIES, INC - Form 483R, 2001-07-27
September, 2000 EIR Epic Pharma, LLC - EIR, 2000-09-06
August, 2001 FDA 483 Bristol-myers Squibb Pharma Company - Form 483, 2001-08-24
August, 2000 FDA 483 Response Perrigo New York, Inc. - Form 483R, 2000-09-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more